×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Theralink Technologies Inc. (THER) OTC MARKETS

$0 - (-)

Market Cap: $6.15M

As of 03/27/24 12:00 AM EDT. Market open.

(THER)

Theralink Technologies Inc. (THER)
OTC MARKETS

$0
- (-)

Market Cap: $6.15M

As of 03/27/24 12:00 AM EDT. Market open.

Add to Portfolio

theralink technologies, inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapy products. the company has proprietary rights to immunotherapy platform focusing on prostate and breast cancers. the company's lead product is proscavax, which is in phase 2 clinical trials for the treatment of prostate cancer. it is also developing targeted therapies. theralink ... read more

theralink technologies, inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapy products. the company has proprietary rights to immunotherapy platform focusing on prostate and breast cancers. the company's lead product is proscavax, which is in phase 2 clinical trials for the treatment of prostate cancer. it is also developing targeted therapies. theralink technologies, inc. has a partnership with perthera, inc. to facilitate and enhance access to theralink's 32 phosphoprotein panel, the theralink assay, for breast cancer patients. the company was formerly known as oncbiomune pharmaceuticals, inc. and changed its name to theralink technologies, inc. in september 2020. theralink technologies, inc. is based in baton rouge, louisiana. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
27
URL
Address
.
PRICE CHART FOR THERALINK TECHNOLOGIES INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$0
Days Range
$0 - $0
52 week range
$0 - $0
Volume
644,147
Avg. Volume (30 days)
2,246,410
Market Cap
$6.15M
Dividend Yield
-
P/E
-
Shares Outstanding
6,151,499,919
Open
-
Previous Close
$0
Days Range
$0 - $0
52 week range
$0 - $0
Volume
644,147
Avg. Volume (30 days)
2,246,410
Market Cap
$6.15M
Dividend Yield
-
P/E
-
Shares Outstanding
6,151,499,919
FINANCIAL STATEMENTS FOR THERALINK TECHNOLOGIES INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR THERALINK TECHNOLOGIES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
KUCHARCHUK ANDREW ALBERTCEO and CFOMay 07, 2020 Option Exercise$0.06283,33417,000290,001May 08, 2020, 05:17 PM
HEAD JONATHAN FREDERICKDirectorMay 07, 2020 Option Exercise$0.06166,66710,000189,236May 08, 2020, 05:14 PM
HEAD JONATHAN FREDERICKChief Executive OfficerSep 02, 2015 Sale$0.001,025,0001,02516,926,078Feb 04, 2016, 05:16 PM
ELLIOT ROBERT LANGE JRDirectorSep 02, 2015 Sale$0.001,025,0001,02516,926,079Feb 04, 2016, 05:14 PM
Leone Group, LLC10% OwnerAug 27, 2015 Option Exercise$0.00666,6662,0001,648,831Sep 15, 2015, 06:06 AM
American Capital Ventures, Inc.10% OwnerAug 27, 2015 Option Exercise$0.00666,6662,0001,648,831Sep 15, 2015, 06:04 AM
Leone Group, LLC10% OwnerJun 17, 2015 Option Exercise$0.003,188,5469,566136,082,500Jun 26, 2015, 09:26 AM
Leone Group, LLC10% OwnerMay 18, 2015 Sale$0.0017,774,1361,777132,893,954Jun 26, 2015, 09:26 AM
American Capital Ventures, Inc.10% OwnerJun 17, 2015 Option Exercise$0.003,188,5469,566136,082,500Jun 26, 2015, 09:23 AM
American Capital Ventures, Inc.10% OwnerMay 18, 2015 Sale$0.0017,774,1361,777132,893,954Jun 26, 2015, 09:23 AM
CARUSONE JOSEPHVP, Investor Relations#Mar 10, 2015 Sale$0.004,200,0004202,100,000Mar 18, 2015, 05:06 PM
DIETRICH ConstantinChief Executive OfficerMar 10, 2015 Buy$0.00300,00030300,000Mar 18, 2015, 01:35 PM
DIETRICH ConstantinChief Executive OfficerMar 10, 2015 Sale$0.00300,000300Mar 18, 2015, 01:35 PM
DIETRICH ConstantinChief Executive OfficerMar 10, 2015 Sale$0.0012,750,0001,2756,375,000Mar 18, 2015, 01:35 PM
DIETRICH ConstantinDirectorApr 05, 2013 Buy$0.014,250,00051,0004,250,000Apr 08, 2013, 03:23 PM
Durrant CameronPresident, CEO, CFO, TreasurerApr 05, 2013 Buy$0.014,250,00051,0000Apr 08, 2013, 01:55 PM
CARUSONE JOSEPHVP, Investor RelationsApr 05, 2013 Buy$0.021,000,00016,8001,400,000Apr 08, 2013, 01:47 PM
CARUSONE JOSEPHVP, Investor RelationsApr 05, 2013 Sale$0.01600,0007,2000Apr 08, 2013, 01:47 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
KUCHARCHUK ANDREW ALBERTCEO and CFO05/07/202017,000
HEAD JONATHAN FREDERICKDirector05/07/202010,000
HEAD JONATHAN FREDERICKChief Executive Officer09/02/20151,025
ELLIOT ROBERT LANGE JRDirector09/02/20151,025
Leone Group, LLC10% Owner08/27/20152,000
American Capital Ventures, Inc.10% Owner08/27/20152,000
Leone Group, LLC10% Owner06/17/20159,566
Leone Group, LLC10% Owner05/18/20151,777
American Capital Ventures, Inc.10% Owner06/17/20159,566
American Capital Ventures, Inc.10% Owner05/18/20151,777
CARUSONE JOSEPHVP, Investor Relations#03/10/2015420
DIETRICH ConstantinChief Executive Officer03/10/201530
DIETRICH ConstantinChief Executive Officer03/10/201530
DIETRICH ConstantinChief Executive Officer03/10/20151,275
DIETRICH ConstantinDirector04/05/201351,000
Durrant CameronPresident, CEO, CFO, Treasurer04/05/201351,000
CARUSONE JOSEPHVP, Investor Relations04/05/201316,800
CARUSONE JOSEPHVP, Investor Relations04/05/20137,200
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR THERALINK TECHNOLOGIES INC
LOADING...